The Francis Crick Institute Jan 16 2025 Researchers at the Francis Crick Institute and Barts Cancer Institute, Queen Mary University of London, have shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy . If integrated into the clinic, testing for this protein could potentially allow hundreds of previously ineligible patients to benefit from this type of treatment. Bowel cancer is the fourth most common cancer in the UK, and